Notícias

Pulsenmore has received the TGA approval (the Australian Therapeutic Goods Administration)

RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health Regulatory Agency (ANVISA), marking a significant milestone in the company’s international expansion.

Pulsenmore has received the TGA approval (the Australian Therapeutic Goods Administration) Read More »

Pulsenmore ES has achieves Brazil’s ANVISA!

RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health Regulatory Agency (ANVISA), marking a significant milestone in the company’s international expansion. This endorsement positions Pulsenmore at the forefront of innovative healthcare, unlocking possibilities for

Pulsenmore ES has achieves Brazil’s ANVISA! Read More »

From start-up nation to innovation nation – joined coverage of Haaretz & NYTimes by the IIA.

Discover Israel’s thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel’s remarkable 75-year history of innovation, highlighting the country’s key contributions to science and technology. One of the featured technologies is Pulsenmore, a remote ultrasound device that’s revolutionizing at-home maternal fetal monitoring.

From start-up nation to innovation nation – joined coverage of Haaretz & NYTimes by the IIA. Read More »